Wordt geladen...
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
Galectin-1 (Gal-1) is involved in several pathological activities associated with tumor progression and chemoresistance, however, the role and molecular mechanism of Gal-1 activity in hepatocellular carcinoma (HCC) epithelial–mesenchymal transition (EMT) and sorafenib resistance remain enigmatic. In...
Bewaard in:
| Gepubliceerd in: | Cell Death Dis |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4855644/ https://ncbi.nlm.nih.gov/pubmed/27100895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2015.324 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|